Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Merck
Medtronic
Baxter
McKesson
McKinsey
Moodys

Last Updated: December 7, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Amibegron

See Plans and Pricing

« Back to Dashboard

What is the development status for investigational drug Amibegron?

Amibegron is an investigational drug.

There have been 4 clinical trials for Amibegron. The most recent clinical trial was a Phase 3 trial, which was initiated on September 1st 2006.

The most common disease conditions in clinical trials are Depressive Disorder, Major, Depressive Disorder, and Depression. The leading clinical trial sponsors are Sanofi and [disabled in preview].

Recent Clinical Trials for Amibegron
TitleSponsorPhase
Efficacy and Safety of SR58611A in Patients With Major Depressive Disorder (SIRIUS)SanofiPhase 3
Long Term Safety and Tolerability of SR58611 in Patients With Major Depressive DisorderSanofiPhase 3
Efficacy and Safety of SR58611 Compared to Placebo and ParoxetineSanofiPhase 3

See all Amibegron clinical trials

Clinical Trial Summary for Amibegron

Top disease conditions for Amibegron
Top clinical trial sponsors for Amibegron

See all Amibegron clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Dow
Johnson and Johnson
Baxter
McKesson
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.